United States Nutrigenomics Market to Grow with a CAGR of 8.60% through 2030

Increasing Prevalence of Chronic Diseases and Rising Demand for Personalized Nutrition are expected to drive the United States Nutrigenomics Market growth in the forecast period, 2026-2030

According to TechSci Research report, “United States Nutrigenomics Market – By Region, Competition, Forecast & Opportunities, 2030F”, the United States Nutrigenomics Market stood at USD 210.75 Million in 2024 and is anticipated to grow with a CAGR of 8.60% in the forecast period, 2026-2030.

Consumers are becoming increasingly aware of the connection between genetics, diet, and overall health, driving a shift toward personalized nutrition solutions. The growing emphasis on self-care and preventive health measures has encouraged individuals to explore DNA-based dietary recommendations. This evolving consumer behavior, combined with rising disposable incomes, is significantly contributing to the growth of the nutrigenomics market.

The sports and fitness industry is also playing a pivotal role in market expansion, as genetic-based performance optimization gains traction among elite athletes, fitness enthusiasts, and sports organizations. By leveraging nutrigenomic insights, individuals can enhance performance, recovery, and endurance, positioning this segment as a key driver for future market growth.

Additionally, government and regulatory support is fostering innovation in the field. U.S. agencies such as the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) are actively funding and endorsing genomics and personalized medicine research. These initiatives are accelerating the adoption of nutrigenomics in both clinical and commercial applications, reinforcing the sector’s long-term potential.

The rise of direct-to-consumer (DTC) genetic testing services has further fueled market expansion, making nutrigenomics more accessible to the general public. Moreover, the integration of digital health technologies and artificial intelligence (AI) is transforming nutrigenomics into a more data-driven and user-friendly experience. AI-powered platforms are enhancing the accuracy of genetic-based nutrition recommendations, creating new opportunities for market growth and technological advancements in the industry.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Nutrigenomics Market”

The United States Nutrigenomics Market is segmented into application, product, technique, end user, regional distribution, and company.

Based on its technique, the buccal swabs segment has emerged as the predominant market leader, The buccal swabs segment holds a dominant position in the United States nutrigenomics market, driven by its non-invasive nature, cost-effectiveness, high accuracy, and widespread adoption in direct-to-consumer (DTC) genetic testing services. As nutrigenomics continues to revolutionize personalized nutrition and wellness, buccal swabs have emerged as the preferred DNA collection technique, supporting market expansion across clinical, commercial, and research applications. the primary reasons for the widespread adoption of buccal swabs is their non-invasive and painless sample collection process. Unlike blood-based genetic testing, which requires professional assistance and laboratory facilities, buccal swabs allow consumers to easily collect DNA samples by swabbing the inner cheek, making them ideal for home-based and clinical use.

Consumers prefer buccal swabs over other methods due to their simple and painless nature, eliminating the need for medical professionals. The technique is particularly beneficial for children, elderly individuals, and people with a fear of needles, increasing its adoption across diverse consumer segments. The rise of DTC genetic testing services, offered by companies like 23andMe, DNAfit, and Nutrigenomix, has fueled demand for buccal swabs, allowing individuals to easily collect samples at home and mail them to laboratories for analysis. This approach aligns with the growing trend of consumer-driven healthcare, where individuals seek personalized insights into their nutrition, metabolism, and genetic predispositions. Buccal swabs provide sufficient DNA quantity and quality for genetic analysis, ensuring accurate and reliable results. Unlike saliva samples, which can be affected by food, drink, or contamination, buccal swabs maintain DNA integrity, making them a preferred choice for nutrigenomics research and diagnostics.

Major companies operating in United States Nutrigenomics Market are:

• BioGaia
• DuPont de Nemours, Inc.
• Nutrigenomix Inc.
• Metagenics, Inc.
• Genova Diagnostics, Inc.
• DNA fit
• MedGenome
• Garden of Life, LLC.
• GeneOmbio
• WellGen Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The United States nutrigenomics market is poised for significant expansion, driven by growing consumer demand for personalized nutrition, advancements in genomic research, and the increasing prevalence of chronic diseases. The integration of artificial intelligence (AI), digital health platforms, and direct-to-consumer (DTC) genetic testing services is further enhancing accessibility and precision, making nutrigenomics a cornerstone of preventive healthcare and wellness strategies. Despite challenges such as regulatory complexities, high costs of genetic analysis, and limited consumer awareness, continuous technological innovations, government support, and expanding applications in sports and clinical nutrition will propel market growth. The dominance of buccal swab-based genetic testing, coupled with the increasing role of data-driven nutritional recommendations, is reshaping the industry’s landscape.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“United States Nutrigenomics Market, By Application (Obesity, Cardiovascular Diseases, Cancer Research, Others), By Product (Reagents & Kits, Services), By Technique (Saliva, Buccal Swab, Blood), By End User (Hospitals & Clinics, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of United States Nutrigenomics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Nutrigenomics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com